All Resources Webinar Replay · Employer Benefits Series

The Hidden Cost Crisis

Why cancer misdiagnosis is quietly draining self-insured health plans, and what benefits leaders can do about it.

Recorded May 28, 2026 60 minutes 3 expert speakers

About this webinar

Cancer is now the #1 driver of high-cost claims for self-insured employers, yet the conversation typically focuses on the wrong number. The real crisis isn’t the headline price tag of a treatment plan — it’s the treatment plans that should never have been written in the first place.

Up to 40% of initial cancer diagnoses are revised after expert review, and nearly as many treatment plans change as a result. For benefits leaders, that’s not a clinical statistic. It’s a budget problem hiding in plain sight.

In this conversation, Dr. Kamal Jethwani (Moffitt Cancer Center), Nisha Gandhi (ClearOnc), and patient advocate Dr. Grace Cordovano unpack where the money is leaking, why standard utilization-management tools miss it, and what employers are doing now to put Moffitt-grade expertise in front of members within days of diagnosis.

What you’ll take away

  • Where misdiagnosis and treatment variation are quietly absorbing 6–8 figures a year inside self-insured health plans
  • Why traditional second-opinion programs underperform — and what changes when expert review happens within days, not weeks
  • What the patient experience actually feels like at diagnosis, and why speed-to-expertise is a clinical and financial lever
  • How leading employers are operationalizing Moffitt-backed expert review without changing carriers, networks, or member workflows
  • A practical framework for evaluating oncology-specific point solutions in your 2026 benefits stack

Curious what this would look like for your population?

We can walk you through what employer partners typically uncover in the first 90 days of expert review — and what it’s worth to your plan.

Let’s Connect More Resources